Astragaloside IV Attenuates Cardiac Aging Through Restoring Mitochondrial Dynamics Homeostasis by Promoting SIRT3-Mediated DRP1 Deacetylation.
Cardiac aging is a major risk factor for cardiovascular diseases, with an imbalance in mitochondrial dynamics homeostasis being a pivotal aspect. Although Astragaloside IV (AS-IV) has been shown to delay aging, its specific effects on cardiac aging and the link to mitochondrial dynamics remain unclear. This study aimed...